Consumer Driven Health Care

Matt Eyles is leaving his CEO post in October after leading AHIP through the COVID-19 pandemic and helping to enact the No Surprises Act legislation, as the association conducts a search for his replacement.

After a pilot program last year, the company is launching its Noom Med option – available in 32 states – that will include prescriptions for Ozempic, Wegovy, Mounjaro and other GLP-1 obesity drugs for about $120 a month.

The outbreak period will end on July 10, 2023 - 60 days after the COVID national emergencies ended - so employers need to decide whether or not to revert to normal cost-sharing for coverage of COVID-19 tests and vaccines.

A more aggressive Federal Trade Commission is starting to target drug mergers and industry middlemen – pharmacy benefit managers, as part of Biden's push for lower drug prices.

How can employers assist members in receiving the right care from the right provider at the right time? Cost and quality navigation overlay programs can help.

As part of the plan, people with traditional Medicare who take insulin will not pay more than $35 for a month's supply beginning July 1.